A detailed history of Alpha Mark Advisors, LLC transactions in Valneva Se stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 150 shares of VALN stock, worth $838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$838
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$5.88 - $8.56 $882 - $1,284
150 New
150 $1,000
Q4 2021

Feb 09, 2022

BUY
$27.1 - $67.28 $2,710 - $6,728
100 New
100 $6,000

Others Institutions Holding VALN

About Valneva SE


  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $386M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.